NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000005963

Registered date:11/07/2011

Case-control study of the effect of HMG-CoA reductases on subarachnoid hemorrhage

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedsubarachnoid hemorrhage due to ruptured cerebral aneurysm and unruptured cerebral aneurysm
Date of first enrollment2009/04/01
Target sample size400
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeInformation of cerebral aneurysms and intake of HMG-CoA reductases
Secondary OutcomeOther clinical information including drug intake other than HMG-CoA reductases

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaCerebral aneurysms due to trauma, dissection, infection, autoimmune diseases, hereditary diseases are excluded.

Related Information

Contact

public contact
Name Kazuhiko Nozaki
Address Seta-Tsukinowa-cho, Otsu Japan
Telephone 077-548-2257
E-mail noz@belle.shiga.med.ac.jp
Affiliation Shiga University of Medical Science Neurosurgery
scientific contact
Name Kazuhiko Nozaki
Address Seta-Tsukinowa-cho, Otsu Japan
Telephone 077-548-2257
E-mail
Affiliation Shiga University of Medical Science Neurosurgery